Cargando…
A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders
Introduction Cardiovascular diseases (CVDs) have become one of the major causes of mortality among the Indian population. The costs of anticoagulant, antiplatelet, and fibrinolytic drugs that are used to treat various thromboembolic disorders and used as prophylactics for individuals at high risk of...
Autores principales: | Ray, Avik, Najmi, Ahmad, Khandelwal, Gaurav, Sadasivam, Balakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273361/ https://www.ncbi.nlm.nih.gov/pubmed/32523821 http://dx.doi.org/10.7759/cureus.7964 |
Ejemplares similares
-
Catastrophic Thromboembolic Syndrome During the COVID-19 Pandemic
por: Udongwo, Ndausung, et al.
Publicado: (2021) -
Peripheral Thromboembolism Formation in a Case of Takotsubo Cardiomyopathy
por: Patel, Reema S, et al.
Publicado: (2022) -
Acute Mesenteric Ischemia With Secondary Thromboembolism: A Rare Complication
por: Figlewicz, Matthew R, et al.
Publicado: (2020) -
Optimizing Computed Tomography for Detection of Pulmonary Thromboembolism in Patients With Fontan Circulation
por: Radwan, Sohab, et al.
Publicado: (2020) -
Balloon Pulmonary Angioplasty for Recurrent Lesions Six Years Following Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
por: Tamura, Hiroto, et al.
Publicado: (2023)